Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Double Blind Randomized Study Comparing Drug Treatment (Tramadol Versus Placebo) and Behavioral Health Treatments (Cognitive Behavioral Therapy Versus Health Education) for Patients With Fibromyalgia

NCT01598753 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT01598753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01598753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Double Blind Randomized Study Comparing Drug Treatment (Tramadol Versus Placebo) and Behavioral Health Treatments (Cognitive Behavioral Therapy Versus Health Education) for Patients With Fibromyalgia
Lead sponsor
University of Washington
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2012
Completion date
July 31, 2018
Enrollment
134 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia